Hits: 772
Aulos Bioscience to Present at the 39th Annual J.P. Morgan Healthcare Conference
BOSTON, MA, USA and TEL AVIV, Israel I January 8, 2021 I ATP, a leading life sciences venture capital firm, and Biolojic Design, a biotechnology company that computationally designs functional antibodies, today unveiled Aulos Bioscience, a new company that is developing highly differentiated interleukin-2 (IL-2)-binding monoclonal antibodies as therapeutics against solid tumors. ATP has committed $40 million in Series A funding to advance Aulos lead molecule from preclinical stage through clinical proof of concept, with human trials expected to start later this year. ATP created Aulos with Biolojic to develop antibodies with unique properties that we believe hold best-in-class promise among IL-2 targeted therapies, said Michael Ehlers, M.D., Ph.D., Chief Scientific Officer of and venture partner at ATP. Biolojic has designed elegant and impressively simple molecules that redirect
Just days after announcing that she is retiring from music amid clashes with her record label, Def Jam, Teyana Taylor was named creative director of the U.K-based retailer PrettyLittleThing.
Her seemingly abrupt career change made headlines, but Taylor tells PEOPLE exclusively that the fashion partnership was no surprise to those closest to her because she has been altering her own looks and styling her friends and family for years. Get push notifications with news, features and more. + Follow
Following You ll get the latest updates on this topic in your browser notifications. They were like, Girl, finally! Taylor, who recently celebrated her 30th birthday, quips. Everybody s very supportive and I think that s all that matters. I think having a great support system plays a part in having peace. Support is the energy. [When] you have support, it just gives you that ammo to really want to be the grea